Zydus Wellness Limited Q2 FY27 Results Awaited After Q1 Revenue Rise

Zydus Wellness Limited is scheduled to report its Q2 FY27 results on November 3, 2026, after reporting Q1 revenue of ₹1,437 crore, up 66.92% year-on-year, while net profit fell 7.04% to ₹118.9 crore. The pending September-quarter statement will provide the next reported comparison for investors.

When will Zydus Wellness report its Q2 FY27 results?

Zydus Wellness is scheduled to discuss its Q2 FY27 performance on November 3, 2026, following the unaudited financial results for the quarter and half-year ended September 30, 2026. The results statement was marked as awaiting publication in the material provided, so no verified Q2 revenue, profit, margin or earnings-per-share figures are available for comparison.

The company has scheduled an investor call at 4:00 p.m. IST on November 3. Chief Executive Officer Tarun Arora and Chief Financial Officer Umesh Parikh are listed as the call hosts. The call is expected to give shareholders an opportunity to hear management's discussion of the quarter and its reported business performance.

The available reporting record identifies the financials as consolidated group results. Until the company publishes the Q2 statement, comparisons with the preceding June quarter and the corresponding quarter a year earlier cannot be made using confirmed data. Investors therefore have only the June-quarter figures as the latest disclosed financial base in the supplied material.

What did Zydus Wellness report in Q1 FY27?

Zydus Wellness reported consolidated total income from operations of ₹1,437 crore for the quarter ended June 2026, compared with ₹860.9 crore in June 2025 and ₹1,484.7 crore in March 2026. This represented year-on-year growth of 66.92%, but a sequential decline of 3.21% from the preceding quarter.

Net sales or income from operations stood at ₹1,429.9 crore, while other operating income was ₹7.1 crore. Consolidated profit after tax was ₹118.9 crore, down 7.04% from ₹127.9 crore in the year-ago period and down 26.60% from ₹162 crore in the March 2026 quarter. The company reported basic earnings per share of ₹3.74 and a net profit margin of 8.27%.

Operating profit was ₹241.7 crore, down 10.51% quarter-on-quarter from ₹270.1 crore. Profit before tax was ₹162.1 crore, compared with ₹177.3 crore in the preceding quarter, a decline of 8.57%. Separately reported EBITDA was ₹245.5 crore, up 54.79% from ₹158.6 crore in the June 2025 quarter.

Why did Q1 profit fall despite higher revenue?

Zydus Wellness recorded lower Q1 net profit despite sharply higher revenue because expenses increased materially during the quarter. Total expenses were ₹1,278.7 crore, compared with ₹718.6 crore in the corresponding quarter of the previous financial year. The expense rise exceeded the pace needed to preserve net profitability on the higher revenue base.

Advertisement and promotion expenditure increased to ₹261.2 crore from ₹132.5 crore a year earlier. The reported figures show that the company continued to spend on brand support while total income grew. The supplied material does not provide a detailed attribution of the full year-on-year profit movement beyond higher expenses.

Sequentially, revenue declined from ₹1,484.7 crore in March 2026 to ₹1,437 crore in June 2026. Operating profit, profit before tax and net profit also declined from the March quarter. These quarterly comparisons describe reported performance and should not be treated as guidance for the pending September-quarter results.

Which businesses supported Zydus Wellness in Q1 FY27?

Zydus Wellness said its core consumer health, nutrition, skincare and personal-care brands supported operational growth in the June quarter. Sugar Free held a 96.1% market share in the sugar substitutes category, according to Nielsen data cited in the supplied material, while Sugar Free D’Lite and I’m Lite delivered double-digit growth.

Glucon-D held a 59.1% share in the glucose category. Nutralite reported double-digit growth and retained leadership in fat spreads, according to company estimates. RiteBite Max Protein continued to lead the nutrition protein bars, cookies and chips segment, while Complan maintained its fourth rank despite a decline in the broader nutritional-drinks category.

In personal care, Everyuth reported market shares of 49.4% in scrubs and 75.5% in peel-off products. It ranked fourth in facial cleansing with an 8.2% market share. Nycil retained leadership in prickly heat with a 32.9% share, while Cuticolor benefited from demand across organised retail channels.

What should investors compare when Q2 FY27 results are released?

Investors will be able to compare Q2 FY27 revenue, profit after tax, margins and EPS with both Q1 FY27 and Q2 FY26 once Zydus Wellness publishes its statement. The supplied record currently has no Q2 FY26 revenue or profit figures, making a complete year-on-year comparison unavailable before the filing.

The main reported Q1 reference points are ₹1,437 crore of total income from operations, ₹118.9 crore of profit after tax and an 8.27% net profit margin. Changes in advertising and promotion costs, total expenses, operating profit and EBITDA will also matter because these items were relevant to the difference between revenue growth and profit growth in the June quarter.

The investor call may provide management commentary on the quarter ended September 30, 2026. However, any assessment of financial performance should be based on the published financial statement and the company’s reported disclosures rather than on unverified estimates or incomplete comparisons.

Conclusion

Zydus Wellness enters its Q2 FY27 reporting date after a June quarter in which consolidated revenue increased 66.92% year-on-year to ₹1,437 crore, but net profit declined 7.04% to ₹118.9 crore. Higher total expenses and advertising and promotion spending were reported alongside growth across several consumer-health and personal-care brands.

The next confirmed update is the Q2 FY27 results statement for the quarter and half-year ended September 30, 2026, followed by the investor call at 4:00 p.m. IST on November 3. Investors will watch for the reported revenue, profitability, expense trend and management’s disclosed discussion of the period.